文献速递细菌感染、耐药与抗菌药物医院感染防控

阿奇霉素群体给药消除沙眼对鼻咽部肺炎链球菌种群结构的影响

Mass drug administration with azithromycin for trachoma elimination and the population structure of Streptococcus pneumoniae in the nasopharynx.
PubMed 文献 · Clin Microbiol Infect · 2020-08-01

该研究分析了冈比亚两个村庄接受第三轮阿奇霉素群体给药前后的514株鼻咽部肺炎链球菌全基因组,发现种群结构变化有限,但一个BAPS克隆群的大环内酯耐药性显著增加,且耐药基因位于可移动遗传元件上。

要点

  • 第三轮阿奇霉素群体给药后肺炎链球菌种群结构变化有限。
  • BAPS17克隆群的大环内酯耐药性在给药后显著增加。
  • 耐药性由可移动遗传元件介导,同时赋予四环素耐药。

核心结论

  • 第三轮阿奇霉素群体给药后肺炎链球菌种群结构变化有限,但BAPS17克隆群的大环内酯耐药性显著增加。

研究设计与样本

  • 研究分析了514株随机选取的鼻咽部肺炎链球菌全基因组,来自冈比亚两个接受三轮年度阿奇霉素群体给药村庄的293名参与者。
  • 514株样本中75%来自0-9岁儿童,分离自第三轮给药前(CSS-1)及给药后1个月(CSS-2)和6个月(CSS-3)的三次横断面调查。

主要发现

  • CSS-1(n=109)和CSS-2(n=69)中未观察到的两个BAPS克隆群在CSS-3(n=126)中频率增加:BAPS20(8.73%,p=0.016)和BAPS22(7.14%,p=0.032),但与抗菌药物耐药无关。
  • BAPS17内的大环内酯耐药在给药后增加(CSS-1 n=0/6,CSS-2/3 n=5/5,p=0.002),且耐药性位于可移动转座元件上,同时赋予四环素耐药。

临床怎么用

  • 在接受阿奇霉素群体给药消除沙眼的地区,应加强肺炎链球菌抗菌药物耐药监测。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Mass drug administration (MDA) with azithromycin for trachoma elimination reduces nasopharyngeal carriage of Streptococcus pneumoniae in the short term. We evaluated S. pneumoniae carried in the nasopharynx before and after a round of azithromycin MDA to determine whether MDA was associated with changes in pneumococcal population structure and resistance. METHODS: We analysed 514 pneumococcal whole genomes randomly selected from nasopharyngeal samples collected in two Gambian villages that received three annual rounds of MDA for trachoma elimination. The 514 samples represented 293 participants, of which 75% were children aged 0-9 years, isolated during three cross-sectional surveys (CSSs) conducted before the third round of MDA (CSS-1) and at 1 (CSS-2) and 6 (CSS-3) months after MDA. Bayesian Analysis of Population Structure (BAPS) was used to cluster related isolates by capturing variation in the core genome. Serotype and multilocus sequence type were inferred from the genotype. Antimicrobial resistance determinants were identified from assemblies, including known macrolide resistance genes. RESULTS: Twenty-seven BAPS clusters were assigned. These consisted of 81 sequence types (STs). Two BAPS clusters not observed in CSS-1 (n = 109) or CSS-2 (n = 69), increased in frequency in CSS-3 (n = 126); BAPS20 (8.73%, p 0.016) and BAPS22 (7.14%, p 0.032) but were not associated with antimicrobial resistance. Macrolide resistance within BAPS17 increased after treatment (CSS-1 n = 0/6, CSS-2/3 n = 5/5, p 0.002) and was carried on a mobile transposable element that also conferred resistance to tetracycline. DISCUSSION: Limited changes in pneumococcal population structure were observed after the third round of MDA, suggesting treatment had little effect on the circulating lineages. An increase in macrolide resistance within one BAPS highlights the need for antimicrobial resistance surveillance in treated villages.

来源:Clin Microbiol Infect,查看原文。版权归原作者所有。

引用

  1. Gladstone RA, Bojang E, Hart J, et al. Mass drug administration with azithromycin for trachoma elimination and the population structure of Streptococcus pneumoniae in the nasopharynx. Clin Microbiol Infect. 2020. PMID: 32750538. doi:10.1016/j.cmi.2020.07.039

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。